Skip to content
Recall Observatory FDA recall evidence

Drug product

Azacitidine for Injection 100 mg/vial For Subcutaneous and Intravenous Use Only Single-Dose Vial Manufactured by Shilpa Medicare Limited Jadcherla -509301 INDIA Distributed by: Cipla USA, Inc. 10 Independence Blvd, Suite 300 Warren, NJ 07059 NDC 69097-805-40

D-0165-2021

December 14, 2020

Class II

Product summary

Firm
CIPLA
Event
Event 86969
Status
Terminated
Classification
Class II
Quantity
2151 vials
Official record key
drug-enforcement:D-0165-2021

Official wording

Reason: cGMP deviations: Vials may not be sealed correctly affecting sterility.

Code information: Lot #: 7S10182A, Ex 9/2021

Distribution pattern: USA Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviations